SilverArc reports 4.8% stake in TELA BIO
SilverArc Capital Management, LLC and Devesh Gandhi report their beneficial ownership in TELA BIO, INC.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
SilverArc Capital Management, LLC and Devesh Gandhi report their beneficial ownership in TELA BIO, INC. Class A Common Stock on an amended Schedule 13G (Amendment No. 2). As of June 30, 2026, they beneficially owned 2,137,201 shares of Class A Common Stock, representing 4.8% of the class. They report no sole voting or dispositive power over these shares, but shared voting and shared dispositive power over all 2,137,201 shares. The filing indicates ownership of 5 percent or less of the outstanding Class A Common Stock.
Key Figures
Key Terms
Schedule 13G/A regulatory
beneficially owned financial
percent of class financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What ownership stake in TELA (TELA BIO, INC.) is reported in this Schedule 13G/A?
Who are the reporting persons in TELA’s (TELA) Schedule 13G/A Amendment No. 2?
Does this Schedule 13G/A show SilverArc and Gandhi as 5% or greater holders of TELA (TELA)?
What key dates are associated with this TELA (TELA) Schedule 13G/A Amendment No. 2?
AI-generated analysis. How Rhea-AI works. Not financial advice.